AstraZeneca has “voluntarily paused” the clinical human trials after unexpected illness in volunteers.
COVID-19 Vaccine Update: In a rather unfortunate turn on the COVID-19 vaccine front, pharmaceutical major AstraZeneca has said that it “voluntarily paused” the clinical human trials of its vaccine candidate ‘Covishield’ with University of Oxford after one of the volunteers developed an unexpected illness. “As part of the ongoing randomized, controlled global trials of the Oxford coronavirus vaccine, our standard review process was triggered and we voluntarily paused vaccination to allow a review of safety data by an independent committee,” the pharma said in a statement. According to…